Basic Information
| LncRNA/CircRNA Name | RP11-513I15.6 |
| Synonyms | NA |
| Region | GRCh38_6:34248568-34286768 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | 2 | ||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | hepatocellular carcinoma blood samples |
| Expression Pattern | differential expression |
| Function Description | The serum exosomal levels of lncRNA-RP11-513I15.6,miR-1262 or RAB11A mRNA showed no significant association with any of the clinical or demographic factors of the malignant group, except forlncRNA-RP11-513I15.6with the mean age. There was a highly significant negative correlation between miR-1262 and lncRNA-RP11-513I15.6 and a negative correlation between miR-1262 and RAB11A mRNA . Furthermore, there was a significant positive correlation between lncRNA-RP11-513I15.6 and RAB11A mRNA. |
| Pubmed ID | 30015383 |
| Year | 2018 |
| Title | Role of Exosomal Competing Endogenous RNA in Patients With Hepatocellular Carcinoma |
External Links
| Links for RP11-513I15.6 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |